Study Comparing Pharmacokinetics, Safety and Immunogenicity of CT-P6 and US-licensed Herceptin

Completed · Phase 1

Conditions studied: Healthy Volunteers

In brief

This is a double-blind, two-arm, parallel-group, single-dose study.

Key facts

Study ID

NCT02665637

Run by

Celltrion

People needed

70

Starts

2015-12-01

Expected to finish

2016-04-01

Last updated by the study team

2016-08-26

Who can join

Age: 18 and older, up to 55. Sex: male. Healthy volunteers: accepted.

You may qualify if…

• Healthy male subject
• Subject voluntarily agrees to participate in this study

You may not qualify if…

• Female.
• Subject has a medical condition of disease including one or more.
• Smoker

Where it is running

• PPD Phase I Clinic — Austin, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.